Back to search

Central venous catheter‐related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors

Data up to Jan 2025

Published2003
Citations39
References26

Total Citations Per Year

Abstract

References (26)

Safety of factor VIII inhibitor bypass activity (FEIBA®): 10‐year compilation of thrombotic adverse events

2002 • 218 citations

Thrombogenicity associated with factor IX complex concentrates.

1991 • 154 citations

Safety and Efficacy of Thrombolytic Therapy for Superior Vena Cava Syndrome

1991 • 134 citations

Guidelines for antithrombotic therapy in pediatric patients

1998 • 119 citations

Catheter-related deep venous thrombosis in children with hemophilia

2001 • 111 citations

Induced immunotolerance in factor VIII inhibitor patients.

1984 • 105 citations

Recombinant factor VIIa (NovoSeven®) and the safety of treatment

2001 • 104 citations

Port‐A‐Cath usage in children with haemophilia: experience of 53 cases

1998 • 88 citations

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with Factor VIII deficiency and a factor VIII inhibitor

1988 • 81 citations

Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors

1999 • 77 citations

The use of central venous catheters (portacaths) in children with Haemophilia

2000 • 66 citations

Prothrombin Concentrates in Treatment of Christmas Disease and Allied Disorders

1969 • 57 citations

The Use of Implantable Venous Access Devices (IVADs) in Children with Hemophilia

1997 • 53 citations

Antihemophilic factor inhibitors. Management with prothrombin complex concentrates

1976 • 53 citations

Fatal Myocardial Infarction Following Therapy with Prothrombin Complex Concentrates in a Young Man with Hemophilia A

1984 • 50 citations

Central venous catheter‐associated thrombosis in severe haemophilia

1999 • 47 citations

Thrombolytic therapy for catheter-related thrombosis

1993 • 45 citations

Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid

1981 • 42 citations

Antihemophilic Factor Inhibitors

1976 • 36 citations

Contrast venography in young Haemophiliacs with implantable central venous access devices

1998 • 34 citations

Use of Prothrombin Complex Concentrates in Hemophiliacs with Inhibitors: Clinical and Laboratory Studies

1978 • 32 citations

Prediction and management of adverse events associated with the use of factor IX complex concentrates.

1993 • 29 citations

Prothrombin Complex Concentrates

1978 • 26 citations

Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate‐related myocardial infarction in patients with haemophilia and inhibitors

2000 • 24 citations

Management of Patients With Factor VIII or IX Inhibitors

2008 • 22 citations

Successful treatment of prolonged superior vena cava syndrome with thrombolytic therapy: A case report

1994 • 16 citations

Cited By (0)

Loading...